| Bristol-Myers Squibb SA - Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml), Konzentrat zur Herstellung einer Infusionslösung |
| 68609 | | 01 | | Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml) | | Konzentrat zur Herstellung einer Infusionslösung | | L01FY02 | | | | 23.12.2022 | | |
|
| Composition |
| relatlimabum 80 mg, nivolumabum 240 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, acidum penteticum, aqua ad iniectabile ad solutionem pro 20 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Nivolumabum | 240mg / 20ml | | Relatlimabum | 80mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Nivolumabum | 240 mg | | Relatlimabum | 80 mg |
| | | | Inactive agents |
|---|
| Acidum Penteticum | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 6432.44 | 6907.50 | A | SL | No |
|
